The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialJ.F.W. Deakin, Graham Dunn, Richard Drake et al.|The Lancet Psychiatry|2018Cited by 180
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Rachel Upthegrove, Lianne Schmaal et al.|Brain Behavior and Immunity|2023Cited by 43
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R. Krynicki, Rachel Upthegrove, Paola Dazzan et al.|Brain Behavior and Immunity|2020Cited by 38